Exact Mass: 229.0254
Exact Mass Matches: 229.0254
Found 79 metabolites which its exact mass value is equals to given mass value 229.0254,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
5-Phosphoribosylamine
5-Phosphoribosylamine is a substrate for Amidophosphoribosyltransferase and Trifunctional purine biosynthetic protein adenosine-3. [HMDB] 5-Phosphoribosylamine is a substrate for Amidophosphoribosyltransferase and Trifunctional purine biosynthetic protein adenosine-3. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
clonidine
C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AC - Imidazoline receptor agonists S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2720 INTERNAL_ID 2720; CONFIDENCE standard compound KEIO_ID C191 Clonidine is an alpha 2-adrenergic agonist[1].
Clonidine
Clonidine, an imidazoline-derivative hypotensive agent is a centrally-acting α2-adrenergic agonist. It crosses the blood-brain barrier and acts in the hypothalamus to induce a decrease in blood pressure. It may also be administered as an epidural infusion as an adjunct treatment in the management of severe cancer pain that is not relieved by opiate analgesics alone. Clonidine may be used for differential diagnosis of pheochromocytoma in hypertensive patients. Other uses for clonidine include prophylaxis of vascular migraine headaches, treatment of severe dysmenorrhea, management of vasomotor symptoms associated with menopause, rapid detoxification in the management of opiate withdrawal, treatment of alcohol withdrawal used in conjunction with benzodiazepines, management of nicotine dependence, topical use to reduce intraocular pressure in the treatment of open-angle and secondary glaucoma and hemorrhagic glaucoma associated with hypertension, and in the treatment of attention-deficit hyperactivity disorder (ADHD). Clonidine also exhibits some peripheral activity. C - Cardiovascular system > C02 - Antihypertensives > C02A - Antiadrenergic agents, centrally acting > C02AC - Imidazoline receptor agonists S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EA - Sympathomimetics in glaucoma therapy D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents N - Nervous system > N02 - Analgesics > N02C - Antimigraine preparations D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Clonidine is an alpha 2-adrenergic agonist[1].
5-phospho-beta-D-ribosylaminium(1-)
5-phospho-beta-D-ribosylaminium(1-) is considered to be soluble (in water) and acidic
2-(2-FORMYLAMINO-1,3-THIAZOL-4-YL)-2-(METHOXYIMINO)ACETIC ACID
Pyrimidine,5-(bromomethyl)-4-(dimethylamino)-2-methyl-(8CI)
2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHANAMINE HYDROCHLORIDE
7-CHLORO-5-(PROPYLTHIO)-1H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE
(z)-2-(2-aminothiazol-4-yl)-2-acetyloxyiminoacetic acid
(5R)-5-(Chloromethyl)-3-(3-fluorophenyl)-2-oxazolidinone
Ethyl 5-Nitro-2,6-Dioxo-3H-Pyrimidine-4-Carboxylate
2,2,2-Trifluoro-1-(3-fluorophenyl)ethylaminehydrochloride
2-(3-METHYL-THIOPHEN-2-YL)-THIAZOLIDINE-4-CARBOXYLIC ACID
1,3-Bis(chloromethyl)-1,1,3,3-tetra methyldisilazane
4-Fluoro-N-methyl-3-(trifluoromethyl)aniline hydrochloride
4-Fluoro-N-methyl-2-(trifluoromethyl)aniline hydrochloride
2-(2-Formamidothiazole-4-yl)-2-methoxyimino acetic acid
(1S)-2,2,2-Trifluoro-1-(4-fluorophenyl)ethanamine hydrochloride ( 1:1)
6-(PYRIDIN-3-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE
6-(PYRIDIN-4-YL)IMIDAZO[2,1-B]THIAZOLE-5-CARBALDEHYDE
5-Phospho-beta-D-ribosylamine
The beta-anomer of 5-phospho-D-ribosylamine. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
